Emily M Cherenack1, Elizabeth E Tolley2, Sylvia Kaaya3, Jennifer Headley4, Joy Noel Baumgartner4. 1. Department of Psychology and Neuroscience, Duke University, 417 Chapel Drive Box 90086, Durham, NC, 27708, USA. emily.cherenack@duke.edu. 2. , FHI 360, 359 Blackwell Street, Durham, NC, 27701, USA. 3. School of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. 4. Duke Global Health Institute, Duke University, 310 Trent Drive, Durham, NC, 27710, USA.
Abstract
PURPOSE: Clinical trials are necessary to test HIV-prevention strategies among adolescent girls and young women in sub-Saharan Africa. Psychosocial risk factors that increase girls' and young women's vulnerability for HIV may also impact their experiences in clinical trials. A better understanding of psychosocial risks among girls and young women enrolled in HIV-prevention research is needed. This analysis explores depression and sexual trauma among adolescent girls and young women enrolled in a mock microbicide trial in Tanzania. METHODS: We collected cross-sectional data from 135 HIV-negative adolescent girls and young women between 15 and 21 in Dar es Salaam, Tanzania enrolled in a mock microbicide trial. Depression, sexual behavior, and sexual trauma were measured. Sexual trauma and demographic variables were entered into a multivariate binomial logistic regression model predicting depression. FINDINGS: Overall, 27% of participants had moderate-to-severe depression. The most commonly endorsed items were anhedonia (lack of interest/pleasure) and low mood, which were reported by 78% of participants. Thoughts of suicide or self-harm were endorsed by 17% of participants. Coerced/forced first sex was reported by 42% of participants. Participants reporting coerced/forced first sex had 3.16 times the likelihood of moderate-to-severe depression. CONCLUSIONS: Depression and coerced/forced sex were common among participants in an HIV-prevention mock clinical trial in Tanzania. When enrolling adolescent girls and young women in HIV-prevention trials in sub-Saharan Africa, our research suggests the need for a trauma-informed approach, referrals for trauma and depression, and interventions that address the impact of depression and trauma on HIV prevention, clinical trial adherence, and clinical outcomes.
PURPOSE: Clinical trials are necessary to test HIV-prevention strategies among adolescent girls and young women in sub-Saharan Africa. Psychosocial risk factors that increase girls' and young women's vulnerability for HIV may also impact their experiences in clinical trials. A better understanding of psychosocial risks among girls and young women enrolled in HIV-prevention research is needed. This analysis explores depression and sexual trauma among adolescent girls and young women enrolled in a mock microbicide trial in Tanzania. METHODS: We collected cross-sectional data from 135 HIV-negative adolescent girls and young women between 15 and 21 in Dar es Salaam, Tanzania enrolled in a mock microbicide trial. Depression, sexual behavior, and sexual trauma were measured. Sexual trauma and demographic variables were entered into a multivariate binomial logistic regression model predicting depression. FINDINGS: Overall, 27% of participants had moderate-to-severe depression. The most commonly endorsed items were anhedonia (lack of interest/pleasure) and low mood, which were reported by 78% of participants. Thoughts of suicide or self-harm were endorsed by 17% of participants. Coerced/forced first sex was reported by 42% of participants. Participants reporting coerced/forced first sex had 3.16 times the likelihood of moderate-to-severe depression. CONCLUSIONS:Depression and coerced/forced sex were common among participants in an HIV-prevention mock clinical trial in Tanzania. When enrolling adolescent girls and young women in HIV-prevention trials in sub-Saharan Africa, our research suggests the need for a trauma-informed approach, referrals for trauma and depression, and interventions that address the impact of depression and trauma on HIV prevention, clinical trial adherence, and clinical outcomes.
Entities:
Keywords:
Clinical trials; Depression; HIV; Mental health; Sexual trauma; Tanzania
Authors: Brian Wells Pence; Michael J Mugavero; Tandrea J Carter; Jane Leserman; Nathan M Thielman; James L Raper; Rae Jean Proeschold-Bell; Susan Reif; Kathryn Whetten Journal: J Acquir Immune Defic Syndr Date: 2012-04-01 Impact factor: 3.731
Authors: Joy Noel Baumgartner; Sylvia Kaaya; Happy Karungula; Anna Kaale; Jennifer Headley; Elizabeth Tolley Journal: Matern Child Health J Date: 2015-01
Authors: Allison P Pack; Jayagowri Sastry; Elizabeth E Tolley; Sylvia Kaaya; Jennifer Headley; Anna Kaale; Joy Noel Baumgartner Journal: AIDS Care Date: 2018-12-31